Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Apollomics A | APLM | 18. oct 2024 | 0.13 | +3.98 |
AppFolio A | APPF | 18. oct 2024 | 201.14 | -0.23 |
Appian A | APPN | 18. oct 2024 | 31.47 | +2.14 |
Apple | AAPL | 18. oct 2024 | 235.00 | +1.23 |
Apple Hospitality REIT | APLE | 18. oct 2024 | 15.00 | -1.51 |
Applied Digital | APLD | 18. oct 2024 | 8.18 | +2.89 |
Applied DNA Sciences | APDN | 18. oct 2024 | 0.32 | +2.11 |
Applied Industrial Technologies | AIT | 18. oct 2024 | 232.07 | -1.31 |
Applied Materials | AMAT | 18. oct 2024 | 186.36 | +1.70 |
Applied Optoelectronics | AAOI | 18. oct 2024 | 18.57 | -2.26 |
Applied Therapeutics | APLT | 18. oct 2024 | 8.96 | +3.82 |
Applovin A | APP | 18. oct 2024 | 145.22 | +1.55 |
AppTech Payments | APCX | 18. oct 2024 | 0.75 | +2.74 |
Aprea Therapeutics | APRE | 18. oct 2024 | 4.40 | -1.12 |
AptarGroup | ATR | 18. oct 2024 | 168.63 | +0.44 |
Aptevo Therapeutics | APVO | 18. oct 2024 | 0.20 | +23.60 |
Aptiv | APTV | 18. oct 2024 | 71.76 | +2.66 |
Aptorum Group A | APM | 18. oct 2024 | 1.71 | +3.01 |
Aptose Biosciences | APTO | 18. oct 2024 | 0.36 | +1.19 |
APx Acquisition I A | APXI | 18. oct 2024 | 11.78 | +0.51 |
APx Acquisition I Unit | APXIU | 18. oct 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | 18. oct 2024 | 1.18 | -0.54 |
Aqua Metals | AQMS | 18. oct 2024 | 0.17 | +14.38 |
AquaBounty Technologies | AQB | 18. oct 2024 | 1.20 | +3.45 |
Aquaron Acquisition | AQU | 18. oct 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | 18. oct 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | 18. oct 2024 | 5.03 | +2.24 |
Aramark | ARMK | 18. oct 2024 | 39.67 | +1.67 |
ARB IOT Group | ARBB | 18. oct 2024 | 0.34 | +8.73 |
Arbe Robotics | ARBE | 18. oct 2024 | 2.01 | -1.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.